If you would like to use the patient decision aid, please contact your neurologist.
We are still conducting pilot testing of the decision aid - if you would like to participate, please contact us here. More information about the study can be found below.
Study: A Patient Decision Aid for Relapsing Multiple Sclerosis Treatments (RMS-PtDA)
Principal Investigator: Dr. Robert Carruthers
Co-Principal Investigator: Dr. Anthony Traboulsee
Purpose
Inclusion criteria
You may qualify as a participant if you meet the following criteria:
What does the study involve?
Over 6 to 7 months, you will be asked to complete 4 surveys, the educational tool (the RMS-PtDA), and participate in a structured follow-up interview. All information collected from your surveys is anonymous.
What are the risks and benefits?
There are no known risks for participating in this study.
You will benefit by being potentially better informed about the treatment options available to you and being able to engage in more meaningful conversations with your doctors before making treatment decisions.
Participation
If you are interested in participating, please contact us here.